Sleep Apnea Implant Market - Growth, Trends, and Forecast (2020 - 2025)
The sleep apnea implant market is expected to register a CAGR of 10.5% during the forecast period.
Sleep apnea implants are preferred compared to traditional CPAP devices as these devices are fully implantable with no masks, hoses which make patient easy to use and make them feel comfortable. These implants are used for the treatment of sleep disorders, like obstructive sleep apnea and central sleep apnea.
The growth of the sleep apnea implants market can be attributed to factors, such as the large pool of undiagnosed sleep apnea patients and growing awareness about the ill effects of untreated sleep apnea.
According to the World Data Analysis by ResMed in 2018 indicates that sleep apnea impacts more than 936 million people worldwide, which is 10 times greater than previous estimates. In addition according to American Seep Apnea Association in United States around 22 million people affects from obstructive sleep apnea out of which 80% moderate and severe cases of OSA are undiagnosed. Moreover, with the increasing obesity worldwide, the sleep apnea patient pool is also expected to grow in forecasted period, which further may increase the chances of adopting sleep apnea implants. However, high cost of sleep apnea implants may hamper the overall market to certain extent.
Key Market Trends
Obstructive Sleep Apnea Segment is Expected to Contribute Higher Market Share in the Sleep Apnea Implant Market
Obstructive sleep apnea is a disorder in which breathing constantly stops and starts during sleep, leading to snoring. This disorder usually happens due to throat muscles intermittently relaxing and blocking the airway during sleep.
A growing number of patients who are not cured by continuous positive airway pressure (CPAP) devices, coupled with increasing prevalence of obstructive sleep apnea, are leading to the adoption of sleep apnea implants. Some of the popular implantable devices in market are AIRLIFT™, remedē® System, and Inspire Therapy.
Hypoglossal neurostimulation devices are a comparatively new, minimally advanced solution, and a new and different approach to treating the obstructive sleep apnea disorder. These devices help in restoring the tone of upper airway dilator muscle, thus, preventing obstruction of the airway. These devices will have a lucrative opportunity in the sleep apnea implant market and are anticipated to show similar trend over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Periodgraphy Trends
North America expected to hold a major market share in the global sleep apnea implant market owing to factors such as rising prevalence of sleep apnea in the region, increasing awareness, favourable reimbursement policies, government initiatives with growing funding. For instance, in 2019 a company named Inspire medical system has received insurance coverage for most sleep apnea patients who meet eligibility requirements for Inspire from majority of healthcare payers. Moreover, changing lifestyle is also leading to rise in obesity prevalence which further result in increase in sleep apnea patient pool and thus increasing pool of patients offer growth opportunities for sleep apnea implant market.
The market is consolidated and consists of major players. Some of the companies which are currently dominating the market are Medtronic, Respicardia Inc., Inspire Medical Systems, Siesta Medical Inc., LivaNova PLC, and LinguaFlex.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook